Intrinsic Value of S&P & Nasdaq Contact Us

Karyopharm Therapeutics Inc. KPTI NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score
41/100
2/7 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow
Analyst Price Target
$14.17
+67.7%

Karyopharm Therapeutics Inc. (KPTI) has 12 identified peers for comparison in the Healthcare sector. Peers include ABOS, AGIO, ASMB, BLUE, CTMX, GBIO and others.

KPTI has a market capitalization of $72.14M, compared to an average peer market cap of $462.28M. KPTI is notably smaller than its average peer.

Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message